Sana Biotechnology, Inc. (SANA)
5.04
+0.10
(+2.02%)
USD |
NASDAQ |
Dec 11, 12:21
Sana Biotechnology Shareholders Equity (Quarterly): 195.31M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Illumina, Inc. | 2.381B |
| Pacific Biosciences of California, Inc. | 36.09M |
| Editas Medicine, Inc. | 13.45M |
| Intellia Therapeutics, Inc. | 748.42M |
| CEL-SCI Corp. | 7.025M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 435.43M |
| Total Liabilities (Quarterly) | 240.12M |
| Debt to Equity Ratio | 0.4211 |
| Current Ratio | 4.555 |
| Net Debt Paydown Yield | 0.35% |